Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

256 Articles

Jon C. Ogg | Feb 1, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

Monday's top analyst calls include Chipotle Mexican Grill, Cisco Systems, Micron Technology, Seagate Technology, VertexPharmaceuticals, Walt Disney and Xerox.

Chris Lange | Jan 31, 2016 at 10:20 AM EST

3 Key FDA Decisions Expected in February

24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the…

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Oct 2, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Friday’s top analyst upgrades, downgrades and initiations include AIG, Facebook, Gilead Sciences, Google, Regeneron Pharmaceuticals, Twitter, Valeant Pharmaceuticals and Vertex…

Chris Lange | Sep 28, 2015 at 12:10 PM EDT

Why Argus Thinks Now Is the Time to Buy Vertex

Argus has been waiting for a better valuation to upgrade Vertex Pharmaceuticals, and the recent weakness in the stock price…

Jon C. Ogg | Sep 28, 2015 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade, Vertex and Many More

Monday's top analyst upgrades, downgrades and initiations include Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade and Vertex Pharmaceuticals.

Jon C. Ogg | Sep 22, 2015 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Apple, DuPont, Frontier Communications, HP, HSBC, 3M, Red Hat and Many More

Tuesday's top analyst upgrades, downgrades and initiations include Apple, DuPont, Frontier Communications, Hewlett-Packard, HSBC, 3M and Red Hat.

Jon C. Ogg | Sep 14, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AeroVironment, Gold Fields, Marvell, Nokia, Silver Wheaton and Many More

Monday's top analyst upgrades, downgrades and initiations include AeroVironment, Gold Fields, Marvell Technology, Nokia and Silver Wheaton.

Lee Jackson | Aug 4, 2015 at 8:35 AM EDT

3 Potential Huge Takeover Targets in Biotech

In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech…

Chris Lange | May 24, 2015 at 9:15 AM EDT

Large Companies With Fastest Revenue and Earnings Growth in 2015

S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.

Lee Jackson | May 7, 2015 at 8:30 AM EDT

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in…

Jon C. Ogg | Apr 10, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Citrix, Kythera, Mylan, Netflix, Weatherford and More

Friday's top analyst upgrades, downgrades and initiations include Apple, Citrix Systems, Kythera Biopharmaceuticals, Mylan, Netflix and Weatherford International.

Lee Jackson | Mar 27, 2015 at 8:35 AM EDT

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

In a new report from RBC, while they think the selling and profit taking in biotechs could go on, they…

Lee Jackson | Mar 25, 2015 at 8:45 AM EDT

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Deutsche Bank says that investors have misread the current instances floating around two leading biotech stocks, and they both should…

Jon C. Ogg | Jan 9, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More

Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include Crocs, Halliburton, Nuance Communications, Staples and…

1 … 8 9 10 11 12 … 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

3 Key FDA Decisions Expected in February

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Why Argus Thinks Now Is the Time to Buy Vertex

Top Analyst Upgrades and Downgrades: Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade, Vertex and Many More

Top Analyst Upgrades and Downgrades: Apple, DuPont, Frontier Communications, HP, HSBC, 3M, Red Hat and Many More

Top Analyst Upgrades and Downgrades: AeroVironment, Gold Fields, Marvell, Nokia, Silver Wheaton and Many More

3 Potential Huge Takeover Targets in Biotech

Large Companies With Fastest Revenue and Earnings Growth in 2015

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

Top Analyst Upgrades and Downgrades: Apple, Citrix, Kythera, Mylan, Netflix, Weatherford and More

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

3 Key FDA Decisions Expected in February

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Why Argus Thinks Now Is the Time to Buy Vertex

Top Analyst Upgrades and Downgrades: Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade, Vertex and Many More

Top Analyst Upgrades and Downgrades: Apple, DuPont, Frontier Communications, HP, HSBC, 3M, Red Hat and Many More

Top Analyst Upgrades and Downgrades: AeroVironment, Gold Fields, Marvell, Nokia, Silver Wheaton and Many More

3 Potential Huge Takeover Targets in Biotech

Large Companies With Fastest Revenue and Earnings Growth in 2015

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

Top Analyst Upgrades and Downgrades: Apple, Citrix, Kythera, Mylan, Netflix, Weatherford and More

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks

Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line